MAPK8 and diabetic neuropathy: It also promoted cellular survival by inhibiting Jun N-terminal kinases (JNK) and extracellular signal−regulated kinase (ERK) signaling pathways induced by oxidative stress, suggesting its potential as a treatment for diabetic neuropathy (Lim et al., 2022[35]).